Swiss National Bank Pacific Biosciences Of California, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Swiss National Bank holds 475,246 shares of PACB stock, worth $926,729. This represents 0.0% of its overall portfolio holdings.

Number of Shares

475,246

Previous 475,246 -0.0%

Holding current value

$926,729

Previous $651,000 23.96%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$3.52 - $9.59 $21,824 - $59,458	6,200 Added 1.32%	475,246 $1.78 Million
Q4 2023 Feb 06, 2024	SELL	$5.97 - $10.36 $315,216 - $547,008	-52,800 Reduced 10.12%	469,046 $4.6 Million
Q3 2023 Nov 08, 2023	BUY	$8.23 - $13.93 $42,796 - $72,436	5,200 Added 1.01%	521,846 $4.36 Million
Q2 2023 Aug 09, 2023	BUY	$9.97 - $14.05 $528,410 - $744,650	53,000 Added 11.43%	516,646 $6.87 Million
Q1 2023 May 10, 2023	SELL	$7.94 - $12.02 $413,674 - $626,242	-52,100 Reduced 10.1%	463,646 $5.37 Million
Q4 2022 Feb 08, 2023	BUY	$5.67 - $11.2 $58,401 - $115,359	10,300 Added 2.04%	515,746 $4.22 Million
Q3 2022 Nov 09, 2022	BUY	$3.93 - $8.57 $38,907 - $84,843	9,900 Added 2.0%	505,446 $2.93 Million
Q1 2022 May 09, 2022	BUY	$8.43 - $20.9 $674,400 - $1.67 Million	80,000 Added 19.25%	495,546 $4.51 Million
Q4 2021 Feb 08, 2022	SELL	$19.26 - $30.08 $17,334 - $27,072	-900 Reduced 0.22%	415,546 $8.5 Million
Q3 2021 Nov 08, 2021	BUY	$24.86 - $35.02 $300,806 - $423,742	12,100 Added 2.99%	416,446 $10.6 Million
Q2 2021 Aug 06, 2021	SELL	$22.3 - $36.02 $44,600 - $72,040	-2,000 Reduced 0.49%	404,346 $14.1 Million
Q1 2021 May 07, 2021	BUY	$26.38 - $51.15 $865,264 - $1.68 Million	32,800 Added 8.78%	406,346 $13.5 Million
Q3 2020 Nov 09, 2020	BUY	$3.61 - $9.87 $238,621 - $652,407	66,100 Added 21.5%	373,546 $3.69 Million
Q2 2020 Aug 05, 2020	BUY	$2.65 - $4.03 $146,280 - $222,456	55,200 Added 21.88%	307,446 $1.06 Million
Q1 2020 May 08, 2020	BUY	$2.36 - $5.26 $8,024 - $17,884	3,400 Added 1.37%	252,246 $772,000
Q4 2019 Feb 06, 2020	BUY	$4.6 - $5.57 $23,919 - $28,964	5,200 Added 2.13%	248,846 $1.28 Million
Q3 2019 Nov 12, 2019	BUY	$4.99 - $6.16 $23,453 - $28,952	4,700 Added 1.97%	243,646 $1.26 Million
Q2 2019 Aug 02, 2019	SELL	$5.92 - $7.41 $31,376 - $39,273	-5,300 Reduced 2.17%	238,946 $1.45 Million
Q1 2019 May 10, 2019	BUY	$6.8 - $7.4 $80,240 - $87,320	11,800 Added 5.08%	244,246 $1.77 Million
Q4 2018 Feb 13, 2019	BUY	$3.99 - $7.82 $32,718 - $64,124	8,200 Added 3.66%	232,446 $1.72 Million
Q3 2018 Nov 08, 2018	BUY	$3.52 - $5.55 $116,160 - $183,150	33,000 Added 17.26%	224,246 $1.21 Million
Q1 2018 May 04, 2018	BUY	$2.05 - $3.23 $46,329 - $72,998	22,600 Added 13.4%	191,246 $392,000
Q3 2017 Nov 03, 2017	BUY	$3.2 - $5.57 $539,667 - $939,358	168,646	168,646 $885,000

Others Institutions Holding PACB

# of Institutions

254

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Pacific Biosciences Of California, Inc. Transaction History